Loading...
An Illustrative Case of Combination Cabozantinib/Nivolumab for Progressive Metastatic Renal Cell Carcinoma (mRCC)
We report a case using combination cabozantinib plus nivolumab to salvage disease control in a patient with refractory metastatic renal cell carcinoma. The patient had previously experienced disease progression from high‐dose interleukin‐2, sunitinib, pazopanib, cabozantinib, and nivolumab, all give...
Na minha lista:
| Udgivet i: | Oncologist |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley & Sons, Inc.
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7930408/ https://ncbi.nlm.nih.gov/pubmed/33251710 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/onco.13617 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|